Mogamulizumab-kpkc and Peginterferon beta-1a
Determining the interaction of Mogamulizumab-kpkc and Peginterferon beta-1a and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: peginterferon beta-1a
Brand name: Plegridy, Plegridy Pen, Plegridy Pen Starter Pack, Plegridy Starter Pack
Synonyms: Peginterferon Beta-1a
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc-Peginterferon beta-1a Subcutaneous
- Mogamulizumab-kpkc-PegIntron
- Mogamulizumab-kpkc-Pegloticase
- Mogamulizumab-kpkc-Pegloticase Intravenous
- Mogamulizumab-kpkc-Pegvaliase
- Mogamulizumab-kpkc-Pegvaliase-pqpz
- Peginterferon beta-1a-Mogamulizumab-kpkc Intravenous
- Peginterferon beta-1a-Molindone
- Peginterferon beta-1a-Mometasone (Oral Inhalation)
- Peginterferon beta-1a-Mometasone and Formoterol
- Peginterferon beta-1a-Mometasone and formoterol Inhalation
- Peginterferon beta-1a-Mometasone Cream